STOCK TITAN
  1. Home
  2. Sec-filings
  3. PROK
  4. [EFFECT] PROKIDNEY CORP. SEC Filing

[EFFECT] PROKIDNEY CORP. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: November 18, 2025
Accession Number: 0001140361-25-038845
Submission Type: POS AM
CIK: 0001850270
Company Name: PROKIDNEY CORP.
File Number: 333-266683

Source: View Original Filing on SEC EDGAR

Stock PROK logo
ProKidney

NASDAQ:PROK

PROK Rankings

#3996 Ranked by Market Cap
N/A Ranked by Dividends

PROK Latest News

Jan 6, 2026
ProKidney to Present at the 44th Annual J.P. Morgan Healthcare Conference
Nov 10, 2025
ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates
Nov 6, 2025
ProKidney Presents Full Results from the Phase 2 REGEN-007 Trial of Rilparencel at the American Society of Nephrology Kidney Week 2025
Oct 29, 2025
ProKidney to Participate in Two Upcoming Conferences: Guggenheim Healthcare Innovation Conference and the Jefferies Global Healthcare Conference
Oct 20, 2025
ProKidney Announces Two Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2025

PROK Latest SEC Filings

Feb 12, 2026
[SCHEDULE 13G] PROKIDNEY CORP. Passive Investment Disclosure (>5%)
Feb 2, 2026
[8-K] PROKIDNEY CORP. Reports Material Event
Jan 12, 2026
[8-K] PROKIDNEY CORP. Reports Material Event
Nov 10, 2025
[10-Q] PROKIDNEY CORP. Quarterly Earnings Report
Nov 10, 2025
[8-K] PROKIDNEY CORP. Reports Material Event

PROK Stock Data

315.65M
105.62M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
WINSTON-SALEM